Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on March 26, 2025

374Water Awarded Aqueous Film-Forming Foam Destruction Contract by the State of North Carolina
Up to 29,000 Gallons Total of AFFF to be Treated by AirSCWO Major Step Forward in the Removal of Harmful Per- and Polyfluoroalkyl Substances (PFAS) From Firefighting Foam DURHAM, N.C., March 26, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“ …

BioCardia Reports 2024 Business Highlights and Financial Results
SUNNYVALE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended …

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care …

Sisecam met with shareholders at its 89th Annual General Assembly
Turkiye Sise ve Cam Fabrikalari AS (IST:SISE) ISTANBUL, TURKEY, March 26, 2025 /EINPresswire.com/ -- Sisecam, a global player in the glass and chemicals industries met with its investors at its 89th Annual General Assembly to share its financial and …

Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
WALTHAM, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) is pleased to announce the appointment of Ajay Royan to its Board of Directors. Mr. Royan is a venture capitalist focused on transformational companies that have solved …

Powata Launches Innovative Virtual Tour Service for Singapore Real Estate Market
Revolutionizing Property Viewing in the Digital Age for the Real Estate Market in Singapore SINGAPORE, SINGAPORE, SINGAPORE, March 26, 2025 /EINPresswire.com/ -- Powata Pte Ltd, a leading technology solutions provider, today announced the launch of its …

Firsthand Technology Value Fund Announces Fiscal Year Financial Results, NAV of $0.15 Per Share
SAN JOSE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, announced today its financial results for the …

3D Systems Reports Fourth Quarter and Full Year 2024 Financial Results
ROCK HILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2024. Full-year 2024 revenue of $440 million, above lower end of guidance …

Concentrix Reports First Quarter 2025 Results
Exceeds first quarter revenue and profit guidance Reiterates full year guidance and remains on track to generate approximately $625 million to $650 million of adjusted free cash flow for the year Expects to return more than $240 million to shareholders in …

Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results
On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our next generation targeted radiopharmaceutical technology …

Jobma Recognized as Momentum Leader and Grid Leader in G2’s Spring 2025 Report
Jobma secures Momentum Leader and Grid Leader awards in G2's Spring 2025 Report, showcasing its impact in transforming modern hiring processes. MINNETONKA, MN, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- Jobma, a leading AI video interviewing …

Dyadic Reports 2024 Year-End Financial Results and Business Updates
Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024 Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to accelerate the C1 platform development timeline to manufacture …

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102
- RT-114 yielded a relative bioavailability of 111% compared to PG-102 delivered subcutaneously with comparable PK profiles, meeting the primary endpoint of demonstrating bioequivalence – - Both groups demonstrated comparable weight loss with less …

Steelcase Reports Fourth Quarter and Fiscal 2025 Results
Fourth quarter results compared to prior year: Orders grew 9%, driven by 12% broad-based growth in the Americas Gross margin improved 70 basis points Fiscal 2025 results: Orders grew 4%, driven by 6% growth in the Americas compared to prior year Gross …

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC) Topline data from registration-intent DENALI Part 2 anticipated by year end 2026 Strengthened management team …

Usio Announces Improved Profitability; Fourth Quarter GAAP Earnings of $0.02 per share and Full Year GAAP Earnings of $0.12 per share
Full Year Revenues up in each of ACH & Complementary Services, Card and Output Solutions Business Units Record Full Year 2024 Dollar Processing Volume of $7.1 Billion, a 33% Increase Compared to Fiscal 2023; Transactions Processed also up a Strong 26% Year …

Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025
PHILADELPHIA, March 26, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced a …

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and neurological diseases Initial data for NKX019 in multiple autoimmune indications expected in second half of 2025 …

Snail, Inc. Reports Fourth Quarter & Full Year 2024 Financial Results
CULVER CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced financial results for its fourth …

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended December 31, 2024 were $56.1 million Met All Financial …